Nottingham University Hospitals sets its sights on HIMSS Level 7

Nottingham University Hospitals NHS Trust has selected Nervecentre to deliver a number of services which include electronic prescribing and medicines administration (EPMA) and FHIR-based interoperability.

The pair have been working together for the last ten years with the trust looking to achieve HIMSS Level 7.

This latest partnership will see the deployment of a range of new modules into inpatient and emergency department areas, including EPMA, structured clinical documentation, discharge summaries, care plans, fluid balance, clinical photography and FHIR-based interoperability.

The new modules will be rolled out over a 12-month period across Nottingham’s two main sites, City Hospital and Queen’s Medical Centre.

Andrew Fearn, director of digital services at the trust, said: “Choosing Nervecentre as our partner for this important digital transformation was an easy choice for us, because our clinicians demand systems that are modern, intuitive and mobile.

“Nervecentre has been at the heart of our digital roadmap for many years and played a crucial role in helping us deliver safe and timely patient care. As we move through the gears of digital maturity and continue our push towards paperless care, it makes sense for us to build around a system that’s loved by clinicians and used routinely by teams both inside our hospitals and out in the community.”

Nottingham has been using Nervecentre’s patient safety solutions since 2010 including sepsis, clinical noting, patient flow, and assessments. In 2015, the trust used money from NHS England’s technology fund to roll out Nervecentre’s electronic observations software.

Paul Volkaerts, founder and CEO of Nervecentre Software, added: “Our goal is to bring EPR systems into the 21st century, by building modern, intuitive, mobile and interoperable systems that clinicians love, not tolerate.

“NUH have always been an exemplar in the selection and adoption of technology, and their ability to adopt, embed and exploit technology to its fullest extent is second to none.”